Diagnostic Value of UTB and TB for PPL
Diagnostic Value of Ultrathin and Thin Bronchoscope for Peripheral Pulmonary Lesions: A Prospective Randomized Controlled Multicenter Study
1 other identifier
interventional
578
1 country
1
Brief Summary
The purpose of the study is to evaluate the diagnostic value and safety of ultrathin and thin bronchoscope (UTB and TB) for peripheral pulmonary lesions (PPLs) without X-ray fluoroscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2020
CompletedFirst Posted
Study publicly available on registry
October 1, 2020
CompletedStudy Start
First participant enrolled
March 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 7, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2022
CompletedSeptember 6, 2023
September 1, 2023
10 months
September 26, 2020
September 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic yield
Diagnostic yield of ultrathin and thin bronchoscope for peripheral pulmonary lesions
Up to 6 months
Secondary Outcomes (6)
Total examination time
During the procedure
Duration of finding lesions
During the procedure
Feature of lesions
Up to 6 months
Difference in the bronchus level reached with the bronchoscope
During the procedure
Difference in diagnostic yield
Up to 6 months
- +1 more secondary outcomes
Study Arms (3)
UTB-VBN-EBUS group
EXPERIMENTALUltrathin bronchoscope with a 3.0-mm outer diameter and a 1.7-mm working channel was used in this group. Specimens were obtained using 1.5-mm biopsy forceps and 1.4-mm cytology brush with the guidance of VBN and EBUS.
TB-VBN-EBUS-GS group
ACTIVE COMPARATORThin bronchoscope with a 4.0-mm outer diameter and a 2.0-mm working channel was used in this group. Specimens were obtained using 1.5-mm biopsy forceps and 1.4-mm cytology brush with the guidance of VBN-EBUS and a 1.95-mm outer diameter guide sheath.
TB-VBN-EBUS-non-GS group
ACTIVE COMPARATORThin bronchoscope with a 4.0-mm outer diameter and a 2.0-mm working channel was used in this group. Specimens were obtained using conventional biopsy forceps and cytology brush with the guidance of VBN and EBUS, but without guide sheath.
Interventions
Ultrathin bronchoscope (UTB) with an outer diameter no more than 3.0-mm and a 1.7-mm working channel.
Thin bronchoscope with a 4.0-mm outer diameter and a 2.0-mm working channel.
VBN can create a path to the target lesion automatically when the lesion is depicted in this software.VBN combined with EBUS can improve the diagnostic yield of PPL and shorten the examination time, which has become the standard method for the diagnosis of PPL.
GS is a cannula with the thinnest outer diameter of 1.95 mm.
Eligibility Criteria
You may qualify if:
- Patients older than 18 years old.
- Chest imaging shows the presence of peripheral pulmonary lesions (defined as those lesions that are surrounded by pulmonary parenchyma and located below the segmental bronchus) that need to be confirmed by pathology. The length diameter of the lesion is no less than 8 mm and no more than 5 cm.
- Patients without contraindications of bronchoscopy.
- Patients have good medical adherence and signed informed consent.
You may not qualify if:
- Peripheral pulmonary lesion is pure ground-glass opacity.
- Absence of bronchus leading to or adjacent to the lesion on thin-slice chest CT.
- Visible lumen lesions in segment and above segment bronchus during bronchoscopy (evidence of endobronchial lesion, extrinsic compression, submucosal tumor, narrowing, inflammation or bleeding of the bronchus).
- Diffuse pulmonary lesions.
- The investigators believe that patient has other conditions that are not suitable for the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shanghai Chest Hospitallead
- The First Affiliated Hospital of Guangzhou Medical Universitycollaborator
- Cancer Institute and Hospital, Chinese Academy of Medical Sciencescollaborator
- West China Hospitalcollaborator
- Henan Provincial People's Hospitalcollaborator
Study Sites (1)
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, 200030, China
Related Publications (8)
Kurimoto N, Miyazawa T, Okimasa S, Maeda A, Oiwa H, Miyazu Y, Murayama M. Endobronchial ultrasonography using a guide sheath increases the ability to diagnose peripheral pulmonary lesions endoscopically. Chest. 2004 Sep;126(3):959-65. doi: 10.1378/chest.126.3.959.
PMID: 15364779BACKGROUNDSteinfort DP, Khor YH, Manser RL, Irving LB. Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis. Eur Respir J. 2011 Apr;37(4):902-10. doi: 10.1183/09031936.00075310. Epub 2010 Aug 6.
PMID: 20693253BACKGROUNDYoshikawa M, Sukoh N, Yamazaki K, Kanazawa K, Fukumoto S, Harada M, Kikuchi E, Munakata M, Nishimura M, Isobe H. Diagnostic value of endobronchial ultrasonography with a guide sheath for peripheral pulmonary lesions without X-ray fluoroscopy. Chest. 2007 Jun;131(6):1788-93. doi: 10.1378/chest.06-2506.
PMID: 17565021BACKGROUNDAsano F, Ishida T, Shinagawa N, Sukoh N, Anzai M, Kanazawa K, Tsuzuku A, Morita S. Virtual bronchoscopic navigation without X-ray fluoroscopy to diagnose peripheral pulmonary lesions: a randomized trial. BMC Pulm Med. 2017 Dec 11;17(1):184. doi: 10.1186/s12890-017-0531-2.
PMID: 29228929BACKGROUNDOki M, Saka H, Asano F, Kitagawa C, Kogure Y, Tsuzuku A, Ando M. Use of an Ultrathin vs Thin Bronchoscope for Peripheral Pulmonary Lesions: A Randomized Trial. Chest. 2019 Nov;156(5):954-964. doi: 10.1016/j.chest.2019.06.038. Epub 2019 Jul 26.
PMID: 31356810BACKGROUNDOki M, Saka H, Ando M, Asano F, Kurimoto N, Morita K, Kitagawa C, Kogure Y, Miyazawa T. Ultrathin Bronchoscopy with Multimodal Devices for Peripheral Pulmonary Lesions. A Randomized Trial. Am J Respir Crit Care Med. 2015 Aug 15;192(4):468-76. doi: 10.1164/rccm.201502-0205OC.
PMID: 26039792BACKGROUNDAsano F, Shinagawa N, Ishida T, Shindoh J, Anzai M, Tsuzuku A, Oizumi S, Morita S. Virtual bronchoscopic navigation combined with ultrathin bronchoscopy. A randomized clinical trial. Am J Respir Crit Care Med. 2013 Aug 1;188(3):327-33. doi: 10.1164/rccm.201211-2104OC.
PMID: 23600452BACKGROUNDFeng X, Zhang Q, Luo F, Zhang X, Zhang L, Xie F, Sun J, Li S. Study design for a multicenter, randomized controlled trial evaluating the diagnostic value of ultrathin bronchoscope compared to thin bronchoscope without fluoroscopy for peripheral pulmonary lesions. J Thorac Dis. 2022 May;14(5):1663-1673. doi: 10.21037/jtd-22-20.
PMID: 35693609DERIVED
Study Officials
- STUDY DIRECTOR
Jiayuan Sun, MD, PhD
Shanghai Chest Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Department of Respiratory Endoscopy, Shanghai Chest Hospital
Study Record Dates
First Submitted
September 26, 2020
First Posted
October 1, 2020
Study Start
March 8, 2021
Primary Completion
January 7, 2022
Study Completion
July 31, 2022
Last Updated
September 6, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share